Predictive modelling of acute Promyelocytic leukaemia resistance to retinoic acid therapy
Briefings in Bioinformatics · 2024
DOI: 10.1093/bib/bbaf002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, 2024. Verfasst von José A Sánchez-Villanueva und 5 weiteren Autor:innen. Beteiligte Einrichtung: Aix Marseille Université, CNRS, I2M, 163 avenue de Luminy, 13009 Marseille, France. Hauptthemen laut MEDLINE: Leukemia, Promyelocytic, Acute, Tretinoin, Drug Resistance, Neoplasm, Antineoplastic Agents. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Acute Promyelocytic Leukaemia (APL) arises from an aberrant chromosomal translocation involving the Retinoic Acid Receptor Alpha (RARA) gene, predominantly with the Promyelocytic Leukaemia (PML) or Promyelocytic Leukaemia Zinc Finger (PLZF) genes. The resulting oncoproteins block the haematopoietic differentiation program promoting aberrant proliferative promyelocytes. Retinoic Acid (RA) therapy is successful in most of the PML::RARA patients, while PLZF::RARA patients frequently become resistant and relapse. Recent studies pointed to various underlying molecular components, but their precise contributions remain to be deciphered. We developed a logical network model integrating signalling, transcriptional, and epigenetic regulatory mechanisms, which captures key features of the APL cell responses to RA depending on the genetic background. The explicit inclusion of the histone methyltransferase EZH2 allowed the assessment of its role in the resistance mechanism, distinguishing between its canonical and non-canonical activities. The model dynamics was thoroughly analysed using tools integrated in the public software suite maintained by the CoLoMoTo consortium (https://colomoto.github.io/). The model serves as a solid basis to assess the roles of novel regulatory mechanisms, as well as to explore novel therapeutical approaches in silico.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Aix Marseille Université, CNRS, I2M, 163 avenue de Luminy, 13009 Marseille, France.
- Integrative molecular biology in hematopoiesis and leukemia, Equipe Labellisée Ligue Contre le Cancer, CRCM, Inserm UMR1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix Marseille Univ, 27 Bd Lei Roure, 13009 Marseille,…
- Department of Biology, École Normale Supérieure, 46 rue d'Ulm, 75005 Paris, France.
- Institut Curie - INSERM U900 - Mines Paris, PSL Research University, 26 rue d'Ulm, 75005 Paris, France.
ORCID-Profile: Denis Thieffry
Zitieren
APA
Sánchez-Villanueva, J. A., N'Guyen, L., Poplineau, M., Duprez, E., Remy, É., & Thieffry, D. (2024). Predictive modelling of acute Promyelocytic leukaemia resistance to retinoic acid therapy. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bbaf002
Vancouver
Sánchez-Villanueva JA, N'Guyen L, Poplineau M, Duprez E, Remy É, Thieffry D. Predictive modelling of acute Promyelocytic leukaemia resistance to retinoic acid therapy. Briefings in Bioinformatics. 2024. doi:10.1093/bib/bbaf002
BibTeX
@article{SnchezVillanueva2024,
author = {Sánchez-Villanueva, José A and N'Guyen, Lia and Poplineau, Mathilde and Duprez, Estelle and Remy, Élisabeth and Thieffry, Denis},
title = {Predictive modelling of acute Promyelocytic leukaemia resistance to retinoic acid therapy},
journal = {Briefings in Bioinformatics},
year = {2024},
doi = {10.1093/bib/bbaf002}
}
EUVIMED